Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology)

by Martin Welschof (Editor), Jürgen Krauß (Editor)

• New

  Illustrated
  2002

  $174.70

  Since the advent of hybridoma technology more than two decades ago, numerous antibodies have entered the clinical setting as potent therapeutic agents. The purpose of Recombinant Antibodies for Cancer Therapy is to present a collection of detailed protocols in recombinant antibody technology.